Business
Novavax to Participate in TD Cowen's 43rd Annual Health Care Conference
GAITHERSBURG, Md., March 6, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™
About this update from Novavax, Inc.
[{"type":"text","content":"GAITHERSBURG, Md., March 6, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced that it will participate in TD Cowen's 43rd Annual Health Care Conference.\nConference Details:\nFireside Chat\nDate:\nWednesday, March 8, 2023\nTime:\n9:50 – 10:20 a.m. Eastern Standard Time (EST)\nLocation:\nBoston Marriott Copley Place in Boston, Massachusetts\nModerator:\nGeorgi Yordanov, Equity Research Analyst – Biotechnology\nNovavax participant:\nJohn Trizzino, Chief Commercial Officer and Chief Business \nOfficer\nConference\nEvent:\nInvestor Meetings\nDate:\nWednesday, March 8, 2023\nRecordingsA replay of the recorded fireside session will be available through the Events & presentations page of the Company's website at ir.novavax.com for 90 days from the date of the conference.\nAbout NovavaxNovavax, Inc. (Nasdaq: NVAX) promotes improved health by discovering, developing and commercializing innovative vaccines to protect against serious infectious diseases. Novavax, a global company based in Gaithersburg, Md., U.S., offers a differentiated vaccine platform that combines a recombinant protein approach, innovative nanoparticle technology and Novavax's patented Matrix-M adjuvant to enhance the immune response. Focused on the world's most urgent health challenges, Novavax is currently evaluating vaccines for COVID-19, influenza, and COVID-19 and influenza combined. Please visit novavax.com and LinkedIn for more information.\nCONTACTS\nInvestors Erika [email protected]\nMediaAli [email protected]\n\n \n\n\n\n View original content to download multimedia:https://www.prnewswire.com/news-releases/novavax-to-participate-in-td-cowens-43rd-annual-health-care-conference-301762705.html\nSOURCE Novavax, Inc.","length":16603,"tagName":"div"}]